glp-1 drugs cost High of weight-loss strains state Medicaid programs The Rising Tide of GLP-1

Eur J Neurosci 49(3):410421 [DOI] [PubMed] [Google Scholar] Bansal AB, Patel P, Khalili Y Al

doi:10.1007/s11886-024-02097-4 6

We have to admit, the clinical trials look pretty good on the surface

56 Recently, an updated multispecialty guidance document (including the ASA) and a multidisciplinary consensus statement (including the Association of Anaesthetists and the Royal College of Anaesthetists) were released, adding to the controversy of periprocedural management of these patients

Additionally, benefits like lowering blood pressure, improving lipid disorders, improving fatty liver disease, reducing your risk of heart disease and kidney disease, and delaying the progression of diabetes-related nephropathy, have been documented